Docking and hydropathic scoring of polysubstituted pyrrole compounds with antitubulin activity

Bioorganic & Medicinal Chemistry
2008.0

Abstract

Compounds that bind at the colchicine site of tubulin have drawn considerable attention with studies indicating that these agents suppress microtubule dynamics and inhibit tubulin polymerization. Data for 18 polysubstituted pyrrole compounds are reported, including antiproliferative activity against human MDA-MB-435 cells and calculated free energies of binding following docking the compounds into models of alphabeta-tubulin. These docking calculations coupled with HINT interaction analyses are able to represent the complex structures and the binding modes of inhibitors such that calculated and measured free energies of binding correlate with an r(2) of 0.76. Structural analysis of the binding pocket identifies important intermolecular contacts that mediate binding. As seen experimentally, the complex with JG-03-14 (3,5-dibromo-4-(3,4-dimethoxyphenyl)-1H-pyrrole-2-carboxylic acid ethyl ester) is the most stable. These results illuminate the binding process and should be valuable in the design of new pyrrole-based colchicine site inhibitors as these compounds have very accessible syntheses.

Knowledge Graph

Similar Paper

Docking and hydropathic scoring of polysubstituted pyrrole compounds with antitubulin activity
Bioorganic & Medicinal Chemistry 2008.0
Pyrrole-Based Antitubulin Agents: Two Distinct Binding Modalities Are Predicted for C-2 Analogues in the Colchicine Site
ACS Medicinal Chemistry Letters 2012.0
Developing novel C-4 analogues of pyrrole-based antitubulin agents: weak but critical hydrogen bonding in the colchicine site
MedChemComm 2013.0
Novel chemotypes targeting tubulin at the colchicine binding site and unbiasing P-glycoprotein
European Journal of Medicinal Chemistry 2017.0
Simple monocyclic pyrimidine analogs as microtubule targeting agents binding to the colchicine site
Bioorganic & Medicinal Chemistry 2023.0
Combretastatin-like chalcones as inhibitors of microtubule polymerisation. Part 2: Structure-based discovery of alpha-aryl chalcones
Bioorganic & Medicinal Chemistry 2009.0
Heterocyclic-Fused Pyrimidines as Novel Tubulin Polymerization Inhibitors Targeting the Colchicine Binding Site: Structural Basis and Antitumor Efficacy
Journal of Medicinal Chemistry 2018.0
Synthesis and Discovery of Water-Soluble Microtubule Targeting Agents that Bind to the Colchicine Site on Tubulin and Circumvent Pgp Mediated Resistance
Journal of Medicinal Chemistry 2010.0
Antitumor Agents. 199. Three-Dimensional Quantitative Structure−Activity Relationship Study of the Colchicine Binding Site Ligands Using Comparative Molecular Field Analysis
Journal of Medicinal Chemistry 2000.0
X-ray Crystallography-Guided Design, Antitumor Efficacy, and QSAR Analysis of Metabolically Stable Cyclopenta-Pyrimidinyl Dihydroquinoxalinone as a Potent Tubulin Polymerization Inhibitor
Journal of Medicinal Chemistry 2021.0